Detalhe da pesquisa
1.
Effect of 3-Dimensional Interstitial High-Dose-Rate Brachytherapy With Regional Metastatic Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: 5-Year Follow-up of a Phase 2 Clinical Trial.
Int J Radiat Oncol Biol Phys
; 115(2): 347-355, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35901979
2.
Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001).
Front Oncol
; 13: 1238553, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37727206
3.
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
Int J Radiat Oncol Biol Phys
; 117(4): 914-924, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356553
4.
Lymph node tuberculosis mimicking malignancy on 18F-FDG PET/CT in two patients: A case report.
Exp Ther Med
; 13(6): 3369-3373, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28587415
5.
Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Int J Radiat Oncol Biol Phys
; 92(5): 1027-1034, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194678